Results 51 to 60 of about 867,189 (360)
Journal of the Royal College of Physicians of London, 1999 A forward looking conference took place at the Royal College of Physicians in June 1998. The audience, which included many scientific and clinical immunologists from both the university and pharmaceutical sector, participated knowledgeably and critically in the discussions on possible future treatments for immunologically caused diseases and on the ...
openaire +2 more sources
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma
, 2022 SIMPLE SUMMARY: Hepatocellular carcinoma is one of the most lethal malignancies, having a significantly poor prognosis. Immunotherapy, as an emerging tumor treatment option, provides new hope for many cancer patients.
Tian, Bao-Wen +11 more
core +1 more source
OncoImmunology, 2018 Memory CD8+ T cell responses have the potential to mediate long-lasting protection against cancers. Resident memory CD8+ T (Trm) cells stably reside in non-lymphoid tissues and mediate superior innate and adaptive immunity against pathogens.
Felipe Gálvez-Cancino +13 more
doaj +1 more source
International Journal of Clinical Practice, 1989 A new era of immunotherapy is arriving in medical therapeutics. Both immunosupresion and immunomodulation have advantages which the clinician must learn. In this review, the author describe several immunomodulators which include cytokines, interleukins, interferons, tumor necrosis factor, granulocyte colony-stimulating factor, erythropoietin, and ...
openaire +4 more sources
Current role of immunotherapy in gastrointestinal cancers
, 2023 Immunotherapy has emerged as a groundbreaking treatment modality in the field of oncology, revolutionizing the management of various cancer types, including gastrointestinal cancers.
Ampah, Richard Kobina
core
Immunotherapy in Advanced Biliary Tract Cancers
, 2021 Biliary tract cancers are rare tumors with a poor prognosis. Two-thirds of these primary liver malignancies are diagnosed at advanced stages where therapeutic options are limited.
Michel Ducreux +5 more
core +1 more source
Nanoscale Research Letters, 2020 Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel ...
Yanling Liu +8 more
doaj +1 more source
Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity
Frontiers in Oncology, 2021 Although abscopal tumor regression remains a rare phenomenon, interest in exploiting how radiation stimulates the immune system to induce systemic abscopal response is increasing.
Jin-Zhi Lai +7 more
doaj +1 more source
Journal of Immunology ResearchMonoclonal antibodies (mAbs) targeting immune checkpoint pathways such as programmed cell death protein 1 (PD-1)/PD-L1 are central to modern immunotherapy, yet scalable methods to assess their functional blockade remain limited.
Veridiane M. Pscheidt +8 more
doaj +1 more source
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Genome Medicine, 2018 For at least 300 years the immune system has been targeted to improve human health. Decades of work advancing immunotherapies against infection and autoimmunity paved the way for the current explosion in cancer immunotherapies.
Samantha L. Bucktrout +2 more
doaj +1 more source